Clinical Trial: Kisspeptin in the Evaluation of Delayed Puberty

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Kisspeptin in the Evaluation of Delayed Puberty

Brief Summary: The investigators are seeking boys (ages 13.5-17 years) and girls (ages 12-17) years with a diagnosis of delayed puberty. Study participation involves 2 outpatient visits and two hospital admissions (one 11-hour, overnight admission and one 6-hour day admission) when subjects will receive two investigational drugs, the naturally occurring hormones kisspeptin and gonadotropin-releasing hormone (GnRH). Subjects will then be followed every 6 months until they reach 18 years of age to determine if their pubertal delay was self-resolved or permanent. Individuals interested in learning more may call 617-724-8592.